UMEDIUM SIGNALFINANCIAL10-K

The company significantly reduced operating losses while adding new AI-focused risk disclosures and substantially increasing current liabilities.

The meaningful improvement in operating losses and net income suggests management's cost reduction efforts may be gaining traction, though the company remains unprofitable. The addition of AI-related risk language indicates strategic product evolution but also acknowledges new competitive and regulatory uncertainties that could impact future performance.

Comparing 2026-02-11 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

The company showed notable improvement in profitability metrics, with operating losses and net income losses both declining meaningfully year-over-year. Cash position strengthened to $2.1B while operating cash flow grew solidly to $423M, indicating better cash generation. However, current liabilities increased substantially to $1.5B, which warrants monitoring for potential working capital pressures or increased operational obligations.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+71.5%
$889.5M$1.5B

Current liabilities surged 71.5% — significant near-term obligations; verify ability to meet short-term debt.

Net Income
P&L
+39.4%
-$664.1M-$402.8M

Net income grew 39.4% — bottom-line growth signals improving overall business health.

Operating Income
P&L
+36.6%
-$755.1M-$479.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Capital Expenditure
Cash Flow
-35.6%
$29.5M$19.0M

Capex reduced 35.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
+35.5%
$1.5B$2.1B

Cash position surged 35.5% — strong cash generation or capital raise providing significant financial cushion.

Operating Cash Flow
Cash Flow
+34%
$315.6M$423.0M

Operating cash flow surged 34% — exceptional cash generation, highest quality earnings signal.

Current Assets
Balance Sheet
+26.4%
$2.2B$2.8B

Current assets grew 26.4% — improving short-term liquidity or inventory/receivables build.

Accounts Receivable
Balance Sheet
+12.2%
$573.9M$643.6M

Receivables grew 12.2% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-02-11
PRIOR — 2025-02-21
ADDED
As of January 30, 2026, there were 432,987,611 shares of the registrant s common stock outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 41 Item 7A.
If we fail to timely release updates and new features to our platform, develop successful new products, or adapt and respond effectively to rapidly changing technology, or to changing customer needs, requirements, or preferences, our platform may become less competitive.
We are increasingly building AI into certain of our offerings, and issues raised by the use of, or failure to successfully use, AI in our offerings, or the use of AI by our customers and competitors may adversely affect our business, reputation, or financial results.
We and the third parties with whom we work are subject to rapidly changing and increasingly stringent laws, regulations, contractual obligations, industry standards and other obligations relating to privacy, data security, and the protection of children.
+7 more — sign up free →
REMOVED
As of February 12, 2025, there were 409,664,525 shares of the registrant s common stock outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 40 Item 7A.
If we fail to timely release updates and new features to our platform and adapt and respond effectively to rapidly changing technology, evolving industry standards, changing regulations, or changing customer needs, requirements, or preferences, our platform may become less competitive.
We periodically review our pricing structure and business models.
Decisions to change how we price our products or services have in the past and may in the future be viewed unfavorably and harm our business.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →